Background: Although fibrin promotes plasminogen activation by tissue-type plasminogen activator by serving as a template, the importance of the plasminogen/fibrin interaction is unclear. Results: Fibrin promoted Lys-and Mini-plasminogen activation to a similar extent even though Mini-plasminogen bound fibrin with 117-fold lower affinity. Conclusion: Kringle 5 of plasminogen is essential for efficient activation by the tissue-type plasminogen activator-fibrin complex. Significance: This study identifies a novel mechanism for regulation of plasminogen activation.
Plasminogen (Pg) is the zymogen of the fibrinolytic enzyme plasmin (Pn). Fibrin (Fn) promotes the activation of Pg by tissue-type plasminogen activator (t-PA) by serving as a template that brings t-PA and Pg into close proximity. In addition, proteolysis of Fn by Pn generates carboxyl-terminal lysine residues that provide nascent high affinity binding sites for Glu-Pg, thereby promoting Pg activation. Pg activation is also enhanced when Glu-Pg is converted to Lys-Pg, a derivative with higher Fn affinity. Therefore, kinetic and functional data suggest that Pg binding to Fn is a key aspect of efficient Pg activation. To explore this concept, we performed binding and kinetic analyses with Mini-Pg, an elastase-derived fragment of Glu-Pg with reduced Fn affinity. Binding of Glu-Pg, Lys-Pg and Mini-Pg to immobilized fibrinogen (Fg) and fibrin monomer (Fm) was monitored by surface plasmon resonance. The affinity of Glu-Pg for Fm is 4-fold higher than that for Fg with Kd values of 3.1 and 12.5 μM, respectively, whereas Lys-Pg binds with high affinity to both Fg and Fm (Kd values of 0.25 and 0.21 μM, respectively). In contrast, Mini-Pg demonstrates weak binding to Fg and Fm with Kd values of 10.5 and 24.5 μM, respectively. To complement the binding experiments, kinetic studies of Pg activation by t-PA were performed in the absence or presence of native Fn clots by monitoring Pn formation using a Pn-directed chromogenic substrate. As expected, the catalytic efficiency of Lys-Pg or Mini-Pg activation by t-PA in the absence of cofactor was higher than that of Glu-Pg (kcat/KM values of 1.3, 0.325, and 0.026 μM−1 min−1, respectively). The catalytic efficiency of Glu-Pg activation by t-PA is 500-fold higher in the presence of Fn than it is in its absence. The stimulatory effect of fibrin was maintained with Lys and Mini-Pg with over 100-fold enhancement in catalytic efficiency of activation. The fibrin-dependent increase in catalytic efficiency was expressed predominantly through a decrease in KM, with values of >20 and 0.2 μM for Glu-Pg activation in the absence and presence of fibrin, respectively. Lys and Mini-Pg also expressed similar enhancements in catalytic efficiency through a decrease in KM. Thus, despite a 100-fold range in their affinities for Fn, the activation of Mini-Pg, Glu-Pg and Lys-Pg by t-PA are all enhanced by at least 2 orders of magnitude in the presence of Fn. These results demonstrate that substrate binding to Fn is not essential for Fn-mediated stimulation of Pg activation by t-PA. To investigate the importance of the Fn-plasminogen activator interaction, activation studies were carried out using urokinase-type plasminogen activator (u-PA), an activator without Fn affinity. In contrast to the results with t-PA, Fn did not enhance u-PA-mediated activation of Glu, Lys or Mini-Pg. The lack of fibrin stimulation of Pg activation by u-PA suggests that the Pg-Fn interaction is not essential to Pg activation. Therefore, the cofactor role of Fn is expressed predominantly through interaction and stimulation of t-PA. These findings support the hypothesis that Fn binding to t-PA may expose cryptic binding sites in the activator that stabilize the formation of the enzyme-substrate complex.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.